Delivery Order SPE2DB20D2104-SPE2DB23FT81H

Award Date 6/2/23
Potential Completion Date 6/5/23
Potential Value $1.9K
Ultimate Awardee
Cencora, Inc.
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award is for the delivery of BIDIL 20 MG-37.5 MG TABLET 90S to the Defense Logistics Agency (DLA). The contract was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract has a ceiling value of $3,361.42 and an ultimate completion date of October 21, 2021. Amerisourcebergen Drug Corp is a subsidiary of Cencora, Inc., which is the parent company. This contract is a delivery order under a larger Indefinite...
This federal contract award is for the delivery of BIDIL 20 MG-37.5 MG TABLET 90S, a pharmaceutical product, to the Defense Logistics Agency (DLA) under a Delivery Order valued at $3,021.61. The prime contractor is Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. This contract is not designated as a set-aside. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary...
This federal contract award is for the delivery of BIDIL 20 MG-37.5 MG TABLET 90S to the Defense Logistics Agency (DLA), a defense agency. The contract was awarded to Amerisourcebergen Drug Corp, a major supplier of pharmaceutical products and medical supplies to the U.S. federal government. The contract is a Delivery Order with a Firm Fixed Price of $2,299.86 and has an ultimate completion date of May 31, 2024. This award is under a larger Indefinite Delivery Contract (IDC) with the DLA Troop...
This contract award, valued at $16,219.51, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of BIDIL 20 MG-37.5 MG TABLET 90S, a pharmaceutical product, and has an ultimate completion date of December 13, 2023. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running through...
This is a federal delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $5,394.32 firm-fixed-price contract is for the delivery of BIDIL 20 MG-37.5 MG tablets. Amerisourcebergen Drug Corp is a subsidiary of the parent company Cencora, Inc. and is registered in the System for Award Management (SAM.gov) through June 2025. The company holds a significant $999,999,999 Indefinite...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of 4567826400 units of BIDIL 20 MG-37.5 MG tablets in 90-count packages, with a ceiling value of $6,596.74. The contract is a Firm Fixed Price Delivery Order, with an ultimate completion date of April 8, 2025. This award is part of a larger $999,999,999 Indefinite Delivery Contract (IDC)...
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract, valued at $3,026.52, is for the delivery of the drug BIDIL 20 MG-37.5 MG TABLET 90S. It is a firm-fixed-price contract with a completion date of November 6, 2024. This award is not designated as a set-aside contract. AmerisourceBergen holds a large Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $10,375.17 Firm Fixed Price Delivery Order contract covers the supply of 4560593667 - BIDIL 20 MG-37.5 MG TABLET 90S, a pharmaceutical product, with a period of performance through April 17, 2023. The award is associated with a larger Indefinite Delivery Contract (IDC) that AmerisourceBergen holds with the DLA Troop...
This federal contract award to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., is for the delivery of Olmesartan-HCTZ 40-25 mg tablets to support federal healthcare programs. The $1,919.59 fixed-price delivery order was awarded by the Defense Logistics Agency (DLA) Troop Support Medical, which is the primary contracting agency for this contract. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as...
This federal contract award, valued at $13,947.35, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The contract is a Delivery Order for the supply of AMLOD-VALSA-HCTZ 5-160-25 MG 30S, a pharmaceutical product, with a period of performance through December 29, 2023. The contract was awarded on a full and open competitive basis without any set-aside designations. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery...
  • SPE2DB20D2104
    Indefinite Delivery Contract
  • SPE2DB20D2104-SPE2DB23FT81H
    Delivery Order

This federal contract award is for the delivery of BIDIL 20 MG-37.5 MG TABLET 90S, a pharmaceutical product, to the Defense Logistics Agency (DLA). The prime contractor is Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract has a ceiling value of $1,937.34 and is a firm fixed-price delivery order with a completion date of June 5, 2023. This contract is not designated as a set-aside.

Amerisourcebergen Drug Corp is a subsidiary of Cencora, Inc., which is the parent company. Cencora, Inc. maintains two Indefinite Delivery Contracts (IDCs) with the DLA Troop Support Medical and the Department of Justice Federal Bureau of Investigation, valued at $999,999,999.00 and $750,000.00, respectively. These IDCs enable the efficient procurement of a comprehensive range of pharmaceutical products and medical supplies to support the healthcare needs of military personnel, veterans, and other federal beneficiaries.

Generated 2/27/25, 10:45 AM